Advocate Hospital System
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Advocate Hospital System sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Advocate Hospital System: 4 sponsored US clinical trials, 1 recruiting.
Advocate Hospital System sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cardiac Arrest, with 1 trials.
Upper-quartile sponsor footprint
Advocate Hospital System sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Association of Near Infrared Spectroscopy With Interstage Outcomes
NCT06538571
Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
NCT00671710
The Effect of Etomidate on Patient Outcomes After Single Bolus Doses
NCT00441792
A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac Arrest
NCT00676598
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
What is open in the Advocate Hospital System pipeline
1 recruiting of 4 indexed (25% open); 3 completed (75%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Cardiac Arrest (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Advocate Hospital System: open-pipeline peers nationwide
Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Advocate Hospital System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
Related
What to do with this Advocate Hospital System page
4 registered trials is a research-attention snapshot, not an endorsement of Advocate Hospital System or any single study.
- 1 of Advocate Hospital System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cardiac Arrest is the condition Advocate Hospital System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cardiac Arrest trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Advocate Hospital System pipeline card: 4 registered trials from official public datasets.Report a data error.